Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations

Chondrosarcoma (CS) is a rare tumour type and the most common primary malignant bone cancer in adults. The prognosis, currently based on tumour grade, imaging and anatomical location, is not reliable, and more objective biomarkers are required. We aimed to determine whether the level of circulating...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyskjær, Iben, Davies, Christopher, Strobl, Anna‐Christina, Hindley, Joanna, James, Steven, Lalam, Radhesh K., Cross, William, Hide, Geoff, Rankin, Kenneth S., Jeys, Lee, Tirabosco, Roberto, Stevenson, Jonathan, O’Donnell, Paul, Cool, Paul, Flanagan, Adrienne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637565/
https://www.ncbi.nlm.nih.gov/pubmed/34528398
http://dx.doi.org/10.1002/1878-0261.13102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637565/
https://www.ncbi.nlm.nih.gov/pubmed/34528398
http://dx.doi.org/10.1002/1878-0261.13102

Ejemplares similares